Disruptive potential of Argentina’s health startups examined

El Economista reports (link in Spanish) that Argentina in particular, and Latin America in general, have the opportunity to play a leading role through startups that combine a high level of talent with new advances in healthcare. This combination, concludes the Argentinian leading economic daily, allows an exponential transformation.

The newspaper reports that venture capital investment in health startups in the region skyrocketed. According to a Pitchbook survey, in 2019, it was US$16 million, an amount that increased fivefold the following year, reaching a total of US$99 million, with a crucial contribution from the private sector.

The article points to the most popular adoption areas: telecare, genomics, advances in the identification and treatment of rare diseases, virtual and augmented reality, artificial intelligence, machine learning, Internet of Things, blockchain. Interestingly, gaps and niches are identified as well, such as a cross between genomics and machine learning. 

Related News

Biomedical Innovations Awarded in Brazil

“Those who innovate to transform lives deserve an award” is the motto of the SBEB-Boston Scientific Award for Innovation in Biomedical Engineering, which encourages the

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner